Corporate overview

Invitrogen Corporation and genOway are working together to provide a complete RNAi solutions platform for the in vivo use of short hairpin RNA (shRNA) to researchers worldwide. This collaboration provides a full service package that takes you from shRNA design and in vitro validation to in vivo gene knockdown in the shortest amount of time.

genOway's proprietary in vivo shRNA technology platform is complemented by Invitrogen's quality BLOCK-iT™ shRNA sequence design and validation services to give you a complete solution that ensures successful RNAi research for drug discovery and therapeutic applications.

Invitrogen's strong RNAi technology portfolio helps researchers achieve robust knockdown, leading to a better understanding of complex biological systems. RNAi Services from Invitrogen offer:

	Expert scientific team with years of knockdown experience
	Fast, reliable results
	Quality RNAi reagents with proven performance
	Expert customer support and consulting

genOway's industry-leading transgenics services now offer Invitrogen's RNAi services which include:

	BLOCK-iT™ shRNA sequence design
	BLOCK-iT™ shRNA validation services

Combining these services provides a complete solution to ensure successful RNAi research for drug discovery and therapeutic applications.

For the most updated information on genOway's RNAi Transgenics platform, or for more information on how RNAi transgenics can help with your research goals, please contact genOway's scientific consultants.